scholarly article | Q13442814 |
P356 | DOI | 10.4021/WJON263W |
P8608 | Fatcat ID | release_yjqoahkw7fgbbpnavde6liy6fm |
P932 | PMC publication ID | 5649748 |
P698 | PubMed publication ID | 29147213 |
P5875 | ResearchGate publication ID | 270087732 |
P2093 | author name string | Hidenori Karasaki | |
Toru Kono | |||
Naoyuki Chisato | |||
Toshiyuki Asama | |||
Yoshiaki Ebisawa | |||
Hiroyuki Furukawa | |||
Kazuo Matsubara | |||
Machiko Satomi | |||
Manabu Suno | |||
P2860 | cites work | Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study | Q34553968 |
Pathobiology of mucositis | Q35707055 | ||
The pathobiology of mucositis | Q35730297 | ||
Anti-inflammatory agents in the management of alimentary mucositis | Q36432423 | ||
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer | Q36443643 | ||
Quaternary protoberberine alkaloids. | Q36655345 | ||
Oral mucositis: review of pathogenesis, diagnosis, prevention, and management | Q36903556 | ||
Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group | Q37381086 | ||
Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet? | Q37594963 | ||
Oral mucositis. Review of literature. | Q37722722 | ||
Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation | Q43548143 | ||
The effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats | Q73792312 | ||
Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels | Q77768417 | ||
Oral mucositis | Q83343556 | ||
P433 | issue | 6 | |
P304 | page(s) | 232-235 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | World journal of oncology | Q27723779 |
P1476 | title | Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis | |
P478 | volume | 1 |
Q52316719 | A Review of Evidence for a Therapeutic Application of Traditional Japanese Kampo Medicine for Oral Diseases/Disorders. |
Q35835142 | Analysis of the antioxidative function of the radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an aqueous phase |
Q37724518 | Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis |
Q40741520 | Effects of Hangeshashinto on Growth of Oral Microorganisms. |
Q47155332 | Efficacy of Banha-sasim-tang on functional dyspepsia classified as excess pattern: study protocol for a randomized controlled trial |
Q35066654 | Herbal medicines for the treatment of cancer chemotherapy-induced side effects |
Q92751411 | How to bridge the gap? European medical plants used for treating oral mucositis: on the search for evidence |
Q60961916 | Kampo (Traditional Japanese Herbal) Formulae for Treatment of Stomatitis and Oral Mucositis |
Q34497892 | Preventive effect of Daiokanzoto (TJ-84) on 5-fluorouracil-induced human gingival cell death through the inhibition of reactive oxygen species production |
Q47102325 | Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer |
Q93075558 | The Biological Efficacy of Natural Products against Acute and Chronic Inflammatory Diseases in the Oral Region |
Q92740178 | The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis |
Q98945639 | The effect of Hangeshashinto on Oral Mucositis Caused by Induction Chemotherapy in Patients with Head and Neck Cancer |
Q26785314 | Traditional Japanese herbal medicines for treatment of odontopathy |